Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2012
06/07/2012WO2012048854A3 Formulation suitable for stabilizing proteins, which is free of mammalian excipients
06/07/2012WO2012048846A3 Phosphate binder formulation for simple ingestion
06/07/2012WO2012039979A3 Rapid diffusion of large polymeric nanoparticles in the mammalian brain
06/07/2012WO2012035478A3 Antifungal varnish composition
06/07/2012WO2012034659A3 Pharmaceutical composition containing an electrochemically activated salt solution
06/07/2012WO2012033983A3 Candesartan pharmaceutical compositions
06/07/2012WO2012014104A3 Composition comprising shellac and/or a salt thereof and sodium starch glycolate
06/07/2012WO2012014052A3 Novel coated extended release pharmaceutical compositions containing paliperidone
06/07/2012WO2012012162A3 Core-sheath implant device having an inner core lobe
06/07/2012WO2011163458A3 Compositions and methods containing alkylgycosides for stabilizing protein- containing formulations
06/07/2012WO2011157722A3 Solid ivabradine-containing composition
06/07/2012WO2011157721A3 Ivabradine-containing pharmaceutical composition
06/07/2012WO2011157416A3 Transdermal administration of memantine
06/07/2012WO2011150239A3 Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
06/07/2012WO2011147536A3 Topical pharmaceutical compositions comprising mometasone furoate
06/07/2012WO2011146808A3 Topical formulation for a jak inhibitor
06/07/2012WO2011117334A3 Reverse micelle system comprising nucleic acids and use thereof
06/07/2012WO2011117333A3 Reverse micelle microemulsion comprising metal ions and use thereof
06/07/2012WO2011116154A3 Melt emulsification
06/07/2012WO2011073234A9 Dry growth hormone composition transiently linked to a polymer carrier
06/07/2012US20120142779 Stable injectable compositions
06/07/2012US20120142737 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
06/07/2012US20120142652 Compositions and methods for localized therapy of the eye
06/07/2012US20120142651 Method of treatment of allergic rhinitis
06/07/2012US20120142638 Combination of organic compounds
06/07/2012US20120142614 Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
06/07/2012US20120142592 Nasal calcitonin formulations containing chlorobutanol
06/07/2012US20120142591 Method of treating intraoccular tissue pathologies with nerve growth factor
06/07/2012US20120142531 Coated Dehydrated Microorganisms with Enhanced Stability and Viability
06/07/2012US20120141796 Co-Flow Microfluidic Device for Polymersome Formation
06/07/2012US20120141592 Controlled-release granular compositions containing mesalazine and process for the manufacture thereof
06/07/2012US20120141591 Drug Delivery Nanocarriers Targeted by Landscape Phage
06/07/2012US20120141590 Technology for the Preparation of Microparticles
06/07/2012US20120141589 Particles for drug delivery and other applications
06/07/2012US20120141588 Dentifrice compositions containing calcium silicate and a basic amino acid
06/07/2012US20120141587 Compositions and methods for treatment or prevention of post-operative organ or tissue inflammation
06/07/2012US20120141586 Thrombin receptor antagonist and clopidogrel fixed dose tablet
06/07/2012US20120141585 Immunomodulatory compositions comprising a polymer matrix and an oil phase
06/07/2012US20120141584 Multilayer Minitablets
06/07/2012US20120141583 Alcohol resistant dosage forms
06/07/2012US20120141582 Thixotropic Oil Based Vehicle for Pharmaceutical Compositions
06/07/2012US20120141581 Capsule and powder formulations containing lanthanum compounds
06/07/2012US20120141580 Capsule formulations containing lanthanum compounds
06/07/2012US20120141579 Cytotoxic T Lymphocyte Inducing Immunogens for Prevention Treatment and Diagnosis of Cancer
06/07/2012US20120141578 Compositions and methods relating to proliferative diseases
06/07/2012US20120141577 Linear expression cassette vaccines
06/07/2012US20120141576 Treatment of Dermatologic Skin Disorders
06/07/2012US20120141575 Collagen For Use In The Treatment Of Skin Diseases
06/07/2012US20120141574 Process for Manufacturing Chewable Dosage Forms for Drug Delivery and Products Thereof
06/07/2012US20120141573 Cell Lines That Secrete Anti-Angiogenic Antibody-Scaffolds and Soluble Receptors and Uses Thereof
06/07/2012US20120141565 Glycerosomes and use thereof in pharmaceutical and cosmetic preparations for topical applications
06/07/2012US20120141564 Compositions and methods of treating inflammation
06/07/2012US20120141563 Pharmaceutical composition including a dha ester to be administered parenterally
06/07/2012US20120141562 Cell coated implantable device
06/07/2012US20120141561 Nanoparticulate candesartan cilexitil compositions, process for the preparation thereof and pharmaceutical compositions containing them
06/07/2012US20120141560 Tumor and infectious disease therapeutic compositions
06/07/2012US20120141559 Bio-membrane for tissue regeneration
06/07/2012US20120141558 Alginate-based nanofibers and related scaffolds
06/07/2012US20120141557 Highly-mineralized osteogenic sponge compositions and uses thereof
06/07/2012US20120141556 Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof
06/07/2012US20120141555 Compound and device for treating bone and/or cartilage defects
06/07/2012US20120141554 Delayed release formulation for reducing the frequency of urination and method of use thereof
06/07/2012US20120141553 Biocompatible polymer fibres for neuroimplants
06/07/2012US20120141552 Ultrasound technology to control the spatial organization of cells and proteins in engineered tissues
06/07/2012US20120141551 Aptamer bioconjugate drug delivery device
06/07/2012US20120141550 System and method for delivery of dna-binding chemotherapy drugs using nanoparticles
06/07/2012US20120141549 Oligonucleotides targeting asthma inflammation processes
06/07/2012US20120141548 Novel formulation of meloxicam
06/07/2012US20120141547 Methods of making cell sheets, tissue sheets and tissue engineered blood vessels
06/07/2012US20120141546 Oil-based preparation
06/07/2012US20120141545 Solid Dosage Form That Promotes Reliable Oral, Esophageal and GI Transit
06/07/2012US20120141544 Solid Dosage Form That Promotes Reliable Oral, Esophageal and GI Transit
06/07/2012US20120141543 Carbon Nanotube Based Nanocomposites
06/07/2012US20120141526 Nanoemulsion vaccines
06/07/2012US20120141386 Application of Antimicrobial and Glycemic Control Activities of Lo Han Kuo Fruit (Siraitia grosvenorii)
06/07/2012US20120141385 Azeotrope-like compositions of tetrafluoropropene and alcohols
06/07/2012US20120141384 Antibacterial conjugated boronic acids and pharmaceutical compositions thereof
06/07/2012US20120141379 Microspheres for active embolization
06/07/2012US20120138056 Dry powder composition comprising co-jet milled particles for pulmonary inhalation
06/07/2012CA2820622A1 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
06/07/2012CA2819858A1 Galenic composition suitable for administration to a nonhuman animal, uses thereof, and associated methods
06/07/2012CA2819635A1 Directed delivery of agents to neural anatomy
06/07/2012CA2819633A1 Pharmaceutical cream compositions and methods of use
06/07/2012CA2819482A1 Flat device for facilitating the transplant of biological material
06/07/2012CA2819471A1 Compounds and methods for skin repair
06/07/2012CA2819460A1 Orally disintegrating tablet
06/07/2012CA2819343A1 Biodegradable natural films based on co-products derived from industrial seed-processing processes
06/07/2012CA2819307A1 Topical compositions for preserving or restoring the integrity of mucosae
06/07/2012CA2819286A1 Microcapsule
06/07/2012CA2819246A1 Liquid viral formulations
06/07/2012CA2819240A1 Aptamer bioconjugate drug delivery device
06/07/2012CA2819236A1 Lyophilized viral formulations
06/07/2012CA2819212A1 Infusion preparation
06/07/2012CA2819206A1 Use of pacap for treating viral infections in aquatic organisms
06/07/2012CA2819039A1 Process for the preparation of a ppi-containing pharmaceutical product
06/07/2012CA2818068A1 Compound formulations
06/07/2012CA2817654A1 Once daily formulation of lacosamide
06/07/2012CA2817618A1 Pharmaceutical compositions
06/07/2012CA2816626A1 Capsule and powder formulations containing lanthanum compounds
06/06/2012EP2460853A1 Water-soluble polymer composition, composition for forming plaster layer of skin patch, and skin patch
1 ... 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 ... 2991